SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040681
Filing Date
2023-08-09
Accepted
2023-08-09 16:38:26
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-20230630.htm   iXBRL 10-Q 3207330
2 EX-10.1 xene-ex10_1.htm EX-10.1 64093
3 EX-31.1 xene-ex31_1.htm EX-31.1 20257
4 EX-31.2 xene-ex31_2.htm EX-31.2 20227
5 EX-32.1 xene-ex32_1.htm EX-32.1 14625
6 EX-32.2 xene-ex32_2.htm EX-32.2 13910
  Complete submission text file 0000950170-23-040681.txt   9169123

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xene-20230630_cal.xml EX-101.CAL 42477
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xene-20230630_lab.xml EX-101.LAB 314680
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xene-20230630.xsd EX-101.SCH 39796
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xene-20230630_pre.xml EX-101.PRE 217335
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xene-20230630_def.xml EX-101.DEF 99871
53 EXTRACTED XBRL INSTANCE DOCUMENT xene-20230630_htm.xml XML 1747035
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 231155815
SIC: 2834 Pharmaceutical Preparations